DE2157333A1 - Pharmazeutisches Präparat - Google Patents

Pharmazeutisches Präparat

Info

Publication number
DE2157333A1
DE2157333A1 DE19712157333 DE2157333A DE2157333A1 DE 2157333 A1 DE2157333 A1 DE 2157333A1 DE 19712157333 DE19712157333 DE 19712157333 DE 2157333 A DE2157333 A DE 2157333A DE 2157333 A1 DE2157333 A1 DE 2157333A1
Authority
DE
Germany
Prior art keywords
pharmaceutically acceptable
hydrogen atom
pharmaceutical preparation
lower alkyl
alkyl radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712157333
Other languages
German (de)
English (en)
Inventor
Oscar Neal Montclair N.J. Miller (V.StA.). A61k 27-00
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2157333A1 publication Critical patent/DE2157333A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE19712157333 1970-11-23 1971-11-18 Pharmazeutisches Präparat Pending DE2157333A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9213770A 1970-11-23 1970-11-23

Publications (1)

Publication Number Publication Date
DE2157333A1 true DE2157333A1 (de) 1972-05-31

Family

ID=22231809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712157333 Pending DE2157333A1 (de) 1970-11-23 1971-11-18 Pharmazeutisches Präparat

Country Status (12)

Country Link
US (1) US3709991A (cg-RX-API-DMAC10.html)
AT (1) AT319240B (cg-RX-API-DMAC10.html)
AU (1) AU456174B2 (cg-RX-API-DMAC10.html)
BE (1) BE775640A (cg-RX-API-DMAC10.html)
CA (1) CA1005342A (cg-RX-API-DMAC10.html)
DE (1) DE2157333A1 (cg-RX-API-DMAC10.html)
FR (1) FR2115358B1 (cg-RX-API-DMAC10.html)
GB (1) GB1344118A (cg-RX-API-DMAC10.html)
IE (1) IE35824B1 (cg-RX-API-DMAC10.html)
IL (1) IL38090A (cg-RX-API-DMAC10.html)
NL (1) NL7116091A (cg-RX-API-DMAC10.html)
ZA (2) ZA717345B (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803592A1 (de) * 1978-01-27 1979-08-02 Scott Eugene J Van Therapeutisches mittel

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891220A (en) * 1988-07-14 1990-01-02 Immudyne, Inc. Method and composition for treating hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803592A1 (de) * 1978-01-27 1979-08-02 Scott Eugene J Van Therapeutisches mittel

Also Published As

Publication number Publication date
AU456174B2 (en) 1974-12-12
ZA717344B (en) 1972-12-27
ZA717345B (en) 1972-11-29
AT319240B (de) 1974-12-10
GB1344118A (en) 1974-01-16
BE775640A (fr) 1972-05-23
FR2115358B1 (cg-RX-API-DMAC10.html) 1975-10-10
CA1005342A (en) 1977-02-15
IL38090A (en) 1974-07-31
NL7116091A (cg-RX-API-DMAC10.html) 1972-05-25
AU3556371A (en) 1973-05-17
IE35824B1 (en) 1976-05-26
FR2115358A1 (cg-RX-API-DMAC10.html) 1972-07-07
US3709991A (en) 1973-01-09
IL38090A0 (en) 1972-01-27
IE35824L (en) 1972-05-23

Similar Documents

Publication Publication Date Title
DE2147794A1 (de) Neue Triazole und diese enthaltende Zubereitungen
DE2017265A1 (de) l-(omega-substituierte-Alkyl)-2mehtylbenzimidazole und Verfahren zu deren Herstellung
EP0117888A1 (de) Flüssigzubereitungen von Dihydropyridinen, ein Verfahren zu ihrer Herstellung, sowie ihre Verwendung bei der Bekämpfung von Erkrankungen
DE2157333A1 (de) Pharmazeutisches Präparat
EP0038438B1 (de) Substituierte 1,2,5-Oxadiazol-2-oxide zur Anwendung als Arzneimittel und sie enthaltende Arzneimittel
DE69132052T2 (de) Uracil-reductase-inaktivator
DE2624558A1 (de) Arzneimittel mit analgetischer wirkung
DE3130912A1 (de) Analgetische arzneimittelkombination
DE3000743A1 (de) Arzneipraeparat auf der basis eines salzes der acetylsalicylsaeure und einer basischen aminosaeure und verfahren zu seiner herstellung
DE3523540A1 (de) Dihydropyridin kombinationspraeparat
DE1964515A1 (de) 1-Substituierte-4-Phenoxypiperidine und Verfahren zu ihrer Herstellung
DE2147882A1 (de) Triazole und tnazolhaltige Arznei mittel
DE2035573A1 (de) Neue Imidazolderivate, ihre Herstellung und die sie enthaltenden medizinischen Zu sammensetzungen
EP0046506A1 (de) Vincamin-saccharinat und dieses enthaltende Arzneimittel
DE1964282A1 (de) Imidazoliumsalze und Verfahren zu deren Herstellung
DE3425466A1 (de) Synergistisches arzneimittelpraeparat zur behandlung von leberkrankheiten
DE3116029A1 (de) 3-deazaadenosin als entzuendungshemmendes mittel
DD242349A5 (de) Verfahren zur herstellung einer synergistischen kombination von flupirtin und 4-acetamido-phenol
DE2322561A1 (de) Trisubstituierte imidazole
DE2242787C2 (de) 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2049115C3 (de) Verwendung von Calcium-5-butylpicolinat und/oder Calcium-5-pentylpicolinat bei der Bekämpfung des Parkinsonismus mit 3-(3,4-Dihydroxyphenyl)-L-alanin (L-Dopa)
DE2000775B2 (de) Substituierte 1,2,3,4-Tetrahydrobenzothieno [23-c] pyridin-Verbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung, die diese Verbindungen enthält
DE3887426T2 (de) Eperisone als Hypotonikum.
EP0061654B1 (de) Vincamin-cyclamat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
DE2055853C3 (de) Procain-Phenylbutazon, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee